Discover 1,461 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
for
Cystic Fibrosis (CF)
Location: Seattle WA, Orange CA, Aurora CO, Plano TX,
Sponsor: State University of New York at Buffalo
Sex: All
Age: 1 - 11
Code: NCT07048574
Recruiting
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Location: Seattle WA, Sacramento CA, Chicago IL, Indianapolis IN,
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 0+
Code: NCT07674758
Recruiting
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Seattle WA, Portland OR, Palo Alto CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 39
Code: NCT04616560
Phase 2, Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Tacoma WA, Edmonton, Walnut Creek CA, Las Vegas NV,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06350097
Phase 3, Recruiting
Optimal Ventilation for Cardiac Arrest
for
Cardiac Arrest (CA)
Location: Seattle WA, Palo Alto CA, Orange CA, Denver CO,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 18
Code: NCT07114510
Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Aurora CO,
Sponsor: University of Iowa
Sex: All
Age: 0+
Code: NCT01193088
Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)